Global Serum-Free Media Market 2023-2029

Global Serum-Free Media Market 2023-2029

Serum-free media are media designed for culturing specific cell types or performing specific applications in the absence of serum. The use of serum-free medium (SFM) is an important tool that allows cell culture to be performed under a defined set of conditions as free as possible of confounding variables. The global serum-free media market was valued at USD 974 million in 2022 to USD 2,319 million by 2029, progressing at a CAGR of 13.2% from 2023 to 2029, according to the latest market study results.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global serum-free media market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for serum-free media can be segmented by product: animal component-free media, chemically-defined media, common serum-free media, protein-free media, xeno-free media. The common SFM segment held the largest share of the global serum-free media market in 2022 and is anticipated to hold its share during the forecast period. Serum-free media market is further segmented by end user: academia and research institutes, clinical research organizations, pharmaceutical and biotechnology companies, others. Globally, the pharmaceutical and biotechnology companies segment made up the largest share of the serum-free media market. Based on region, the serum-free media market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global serum-free media market in 2022.

Market Segmentation
By product: animal component-free media, chemically-defined media, common serum-free media, protein-free media, xeno-free media
By end user: academia and research institutes, clinical research organizations, pharmaceutical and biotechnology companies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global serum-free media market report offers detailed information on several market vendors, including Athena Environmental Sciences, Inc., Corning Incorporated, Danaher Corporation (Cytiva), FUJIFILM Holdings Corporation, Lifeline Cell Technology, LLC (International Stem Cell Corporation), Lonza Group AG, Merck KGaA, MP Biomedicals, Inc. (Valiant Co., Ltd.), PAN-Biotech GmbH, PromoCell GmbH, R&D Systems, Inc. (Bio-Techne Corporation), Sartorius AG, Sino Biological, Inc., STEMCELL Technologies Inc., Takara Bio, Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Scope of the Report

• To analyze and forecast the market size of the global serum-free media market.
• To classify and forecast the global serum-free media market based on product, end user, region.
• To identify drivers and challenges for the global serum-free media market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global serum-free media market.
• To identify and analyze the profile of leading players operating in the global serum-free media market.


Why Choose This Report
• Gain a reliable outlook of the global serum-free media market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.